NZX results archive

NZX company results and financial reports.

Read what changed in the latest company results, compare equivalent periods, and open issuer-labelled annual reports and other source documents where available.

NZX results and source reports

Stop rebuilding company histories one PDF at a time.

Annolyse connects each full-year or half-year result with the prior equivalent period, the company’s longer financial history, and the source documents used in the analysis.

Read the latest result

Each briefing explains what changed, what matters, what remains unresolved, and which filing pages support the analysis.

Follow one company

Use the company directory to move from a single announcement to the complete result archive and filing-only metric history.

Browse company histories →

Prepare for the next result

Check the results calendar, then revisit the previous briefing’s expectations before the next filing arrives.

Open results calendar →

Annolyse analyses issuer filings; it does not replace them. Source labels are preserved: a full-year financial report is not automatically reclassified as an annual report. Open the documents inside each briefing and read the methodology before relying on a comparison.

All results Consumer Healthcare Transport & Infrastructure Property Primary Industries Investment Companies Construction & Materials Technology

Search company archive

Company archive

Sector archive

Search company archive

Open archive

Company archive

Sector archive

Clear filters

Showing 1-24 of 756 published briefings.

Rua Bioscience (RUA)FY26Released 28 August 2026

Revenue rose 93.5% while borrowings climbed 55.9%

Revenue reached $2.9m and cash rose to $0.534m, but operating cash outflow widened to $3.0m.

Published 29 August 2026

NZX company results and financial reports.

Stop rebuilding company histories one PDF at a time.

Read the latest result

Follow one company

Prepare for the next result

Revenue rose 93.5% while borrowings climbed 55.9%

Underlying NPAT rose 23.2% despite reported profit falling 10.0%

EBITDA hit a record $134.5m but a $30.9m charge cut NPAT 19.4%

Air New Zealand swings to a $336.0m pretax loss on fuel costs

Capital raise puts Comvita's debt headroom in focus

Underlying profit fell 3% while statutory PBT jumped 63.1%

Capital raise puts Genesis Energy's debt headroom in focus

NZL's NPAT grew 34.3% but operating cash flow fell 43.9%

Winton revenue rose 21.5% as net debt fell to NZ$5.4m

Revenue up 13.9% but EBITDA margin fell to -10.4%, PBT down 149.7%

Capital raise puts Meridian Energy Limited's debt headroom in focus

Revenue up 104.9% but EBITDA fell 7.8% on a lower-margin mix shift

MOVE returns to profit as receivables rise

PBT growth of n/m reflects a one-off-depressed FY25 base

Portfolio loss drives $17.3m net loss as NTA falls to $0.80

Barramundi NTA per share sinks to $0.53 as portfolio drives $42.9m net loss

Chorus PBT rose 228.6% but a tax swing drove NPAT's 825% jump

PFI free cash flow swings to -$50.2m on a debt-funded capex surge

Record NPAT hides cash conversion drop to 79% from 115%

Skellerup records tenth normalised EBIT increase as insurance gain lifts headline

SkyCity underlying EBITDA meets guidance as reported NPAT falls 37.6%

Headline FY26 growth outpaces flat underlying trading performance

Cash conversion fell to 66.1% as a lower tax rate lifted NPAT 20.1%

Capex-driven cash burn pushes leverage higher as PBT falls 18.6%

Get reporting-season briefings